Orexo (Sweden)

Recent papers from Orexo (Sweden)

1. High-content morphological profiling by Cell Painting in 3D spheroidsNature Communications · 2026
2. Abstract 7913: OXC-101 (karonudib) in canine lymphoma and hemangiosarcoma: Safety, early efficacy, and translational potentialCancer Research · 2026
3. Efficiency and pitting resistance of mechanochemically finished gearsResults in Engineering · 2025
4. A bi-material FDM system with reinforced mixing and cooling for uniform material mixing and broad functionalityProgress in Additive Manufacturing · 2024
5. p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenograftsEuropean Journal of Nuclear Medicine and Molecular Imaging · 2023
6. Engineered microparticles of hyaluronic acid hydrogel for controlled pulmonary release of salbutamol sulphateInternational Journal of Pharmaceutics · 2023
7. Neutralizing antibody creation technologies: case of SARS-CoV-2Medicine of Extreme Situations · 2022
8. Oral transmucosal delivery of eletriptan for neurological diseasesInternational Journal of Pharmaceutics · 2022
9. Effect of pressure drop on the in vitro dispersion of adhesive mixtures of different blend states for inhalationInternational Journal of Pharmaceutics · 2022
10. Resilient Conflict-free Replicated Data Types without Atomic Broadcast2022
11. GeoRep—Resilient Storage for Wide Area NetworksIEEE Access · 2022
12. Major sex differences in migraine prevalence among occupational categories: a cross-sectional study using UK BiobankThe Journal of Headache and Pain · 2021
13. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid LeukemiaCancer Research · 2021
14. High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysisJournal of Translational Medicine · 2021
15. Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell CarcinomaCancer Immunology Research · 2020
16. Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for AsthmaJournal of Medicinal Chemistry · 2019
17. Investigation through Artificial Neural Networks on the Influence of Shot Peening on the Hardness of ASTM TX304HB Stainless SteelJournal of Testing and Evaluation · 2019
18. Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension StudyJournal of Addiction Medicine · 2017
19. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trialJournal of Addictive Diseases · 2016
20. Effects of a Higher-bioavailability Buprenorphine/Naloxone Sublingual Tablet Versus Buprenorphine/Naloxone Film for the Treatment of Opioid Dependence During Induction and Stabilization: A Multicenter, Randomized TrialClinical Therapeutics · 2015